Back
Brookline Bancorp Vs. Keros Therapeutics Industry Stock Comparison
Sell
30
BRKL
Brookline Bancorp
Last Price:
9.97
Seasonality Move:
4.69%
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
Sell
30
Brookline Bancorp (BRKL)
is a Sell
Is Brookline Bancorp a Buy, Sell or Hold?
- The current Brookline Bancorp [BRKL] share price is $9.96. The Score for BRKL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- BRKL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.45. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BRKL Stock Price Chart
What is Brookline Bancorp's stock price today?
-
The Brookline Bancorp share price today is $9.96
The current trend is moderately bearish and BRKL is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
BRKL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 47.83 | Sell |
Chaikin Money Flow: | -414055 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.9 - 10.24) | Sell |
Bollinger Bands (100): | (8.59 - 10.11) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.11 | Buy |
Relative Strength Index (14 RSI): | 62.18 | Buy |
Chaikin Money Flow: | -153833 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.11 - 57.09) | Buy |
Bollinger Bands (100): | (45.06 - 53.7) | Buy |
BRKL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.19 | Sell |
20-day SMA: | 10.05 | Sell |
50-day SMA: | 10 | Sell |
200-day SMA: | 9.65 | Buy |
8-day EMA: | 10.09 | Sell |
20-day EMA: | 10.06 | Sell |
50-day EMA: | 9.86 | Buy |
200-day EMA: | 9.63 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.1 | Buy |
20-day SMA: | 54.42 | Buy |
50-day SMA: | 50.2 | Buy |
200-day SMA: | 52.84 | Buy |
8-day EMA: | 56 | Buy |
20-day EMA: | 54.17 | Buy |
50-day EMA: | 51.53 | Buy |
200-day EMA: | 49.92 | Buy |
Brookline Bancorp Earnings Growth & BRKL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.21 per share, and an increase next year of $0.20 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
Brookline Bancorp Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |